Characteristic of FINDRISC Score and Association with Diabetes Development in 6-Year Follow-Up in PURE Poland Cohort Study.
diabetes
epidemiology
preventive medicine
Journal
Vascular health and risk management
ISSN: 1178-2048
Titre abrégé: Vasc Health Risk Manag
Pays: New Zealand
ID NLM: 101273479
Informations de publication
Date de publication:
2021
2021
Historique:
received:
25
05
2021
accepted:
24
08
2021
entrez:
6
10
2021
pubmed:
7
10
2021
medline:
29
12
2021
Statut:
epublish
Résumé
The aim of the study was to assess if FINDRISC score was associated with diabetes development after 6 years of observation. Polish cohort is a part of global PURE study. Hereby analysis presents data from baseline (2007-2010) and 6-year follow-up (2013-2016) and was conducted on 1090 participants (702 women) from urban and rural areas in Lower Silesia region (Poland) without diabetes at the baseline and with complete data throughout course of the study. At the baseline, women had significantly higher FINDRISC score than men (10.43 vs 8.91; p=0.000) and participants from rural areas had higher score than from urban areas (10.97 vs 9.33; p=0.000). At the baseline, 25.87% of the participants had low risk of diabetes according to FINDRISC score, 38.90% had slightly elevated risk, 16.79% moderate risk, 16.42% high risk and 2.02% very high risk. Participants, who were healthy at baseline, but developed diabetes after 6 years of observation had significantly higher FINDRISC, than those who did not (13.39 vs 9.36; p=0.000). In 6-year follow-up, diabetes was diagnosed in 2.8% of participants, who were ascertained to "low risk" according to FINDRISC score in baseline; in 9.9% of participants of "slightly elevated risk", 17.5% of participants of "moderate risk", 26.8% in participants of "high risk" and 50.0% of participants of "very high risk". Results of PURE Poland cohort study indicates that higher FINDRISC score at the baseline was associated with higher risk of diabetes development during 6 years of observation.
Identifiants
pubmed: 34611406
doi: 10.2147/VHRM.S321700
pii: 321700
pmc: PMC8486267
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
631-639Informations de copyright
© 2021 Zatońska et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
J Clin Endocrinol Metab. 2009 Mar;94(3):920-6
pubmed: 19106274
Lancet Diabetes Endocrinol. 2014 Jan;2(1):19-29
pubmed: 24622666
Diabetes Res Clin Pract. 2013 Dec;102(3):202-9
pubmed: 24262944
Eur J Public Health. 2013 Dec;23(6):991-7
pubmed: 23243133
Diabetes Res Clin Pract. 2011 Apr;92(1):46-52
pubmed: 21242013
Diabetol Metab Syndr. 2018 Mar 1;10:12
pubmed: 29507612
Am J Cardiol. 2008 Aug 15;102(4):497-8
pubmed: 18678313
BMJ Open Diabetes Res Care. 2016 Jun 22;4(1):e000217
pubmed: 27403326
Int J Epidemiol. 2011 Jun;40(3):804-18
pubmed: 21335614
Diabetes Care. 2003 Dec;26(12):3230-6
pubmed: 14633807
Diabetes Res Clin Pract. 2019 Apr;150:99-110
pubmed: 30796939
N Engl J Med. 2002 Feb 7;346(6):393-403
pubmed: 11832527
BMC Public Health. 2020 Jun 3;20(1):843
pubmed: 32493306
Environ Health Prev Med. 2016 Nov;21(6):470-479
pubmed: 27699688
BMJ Open Diabetes Res Care. 2019 Nov 28;7(1):e000769
pubmed: 31803483
Am Heart J. 2009 Jul;158(1):1-7.e1
pubmed: 19540385
N Engl J Med. 2017 Apr 13;376(15):1407-1418
pubmed: 28402770
Diabetes Res Clin Pract. 2012 Jun;96(3):271-85
pubmed: 22261096
Diabetes Obes Metab. 2017 Sep;19(9):1260-1266
pubmed: 28321981
Public Health. 2012 Oct;126(10):813-20
pubmed: 22922043
Diabetologia. 2008 Nov;51(11):1971-9
pubmed: 18779946
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
J Hum Nutr Diet. 2012 Jun;25(3):225-32
pubmed: 22390143
Diabetes Care. 2003 Mar;26(3):725-31
pubmed: 12610029
Eur Heart J. 2013 Oct;34(39):3035-87
pubmed: 23996285